Full-Time

Research Associate/Sr. Research Associate

Posted on 3/21/2023

Beam Therapeutics

Beam Therapeutics

201-500 employees

Pioneering precision genetic medicines through CRISPR base editing

Biotechnology

Senior

Cambridge, MA, USA

Required Skills
Communications
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • BS in Chemistry, Biochemistry, Chemical Biology, Molecular Biology, Biotechnology, Chemical Engineering or equivalent and a minimum of 1 year (RA) to 4 years (Sr. RA) of experience in protein biochemistry
  • Familiarity operating AKTA FPLC instruments
  • Theoretical and practical knowledge on purification sciences with an emphasis on strategies applied to the purification of biological macromolecules
  • Proficient in molecular biology applications including primer design cloning, DNA purification and quantification methods
  • Candidate must be familiar running various protein characterization assays (SDS-PAGE, UV-VIS spectroscopy)
  • Self-driven, analytical, and detail-oriented scientist with a strong problem-solving mindset and a strong curiosity towards areas of protein science previously unknown to you
  • Excellent written and verbal communication skills with the ability to present effectively to teams with diverse scientific backgrounds
  • Familiarity with the use of ELNs and inventory management
  • Familiarity with DoE approaches for the improvement of purification processes
  • Familiarity with plasmid mechanics (g. selection of RBS strength, promoter strength, protein induction strategies)
  • Familiar with the use of programs like MS Excel, MS PowerPoint, GraphPad Prism, Geneious, and JMP
Responsibilities
  • Contribute to the scientific strategy, discussion, and output of the team
  • Perform and evaluate studies to improve yield and purity of purified targets
  • Perform protein expression and purification of novel base editors and proteins of interest
  • Assist in method development campaigns to assess robustness of purification strategies
  • Assist in the design and implementation of activity and release criteria assays of purified base editors/target proteins
  • Assess scientific literature and properly apply it to increase knowledge base
  • Document, present, and communicate scientific findings

Beam Therapeutics, established in 2018, is a pioneer in the field of genetic medicine, utilizing CRISPR base editing to create precise, permanent alterations to single bases in DNA and RNA without breaking the strands. The company's culture is characterized by a community of fearless innovators, rigorous and honest research, open-mindedness, and commitment to each other. Their competitive advantage lies in their unique delivery strategy, which includes a range of clinically validated technologies such as electroporation, nonviral, and viral delivery modalities, positioning them as a leader in the genetic medicine industry.

Company Stage

IPO

Total Funding

$689M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

-8%

1 year growth

-11%

2 year growth

20%
INACTIVE